4.6 Article

Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells

Journal

JAMA ONCOLOGY
Volume 2, Issue 9, Pages 1197-1206

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2016.0605

Keywords

-

Categories

Funding

  1. National Institutes of Health [P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, K07 CA190673, P50 CA127003, R01 CA151993, R35 CA197735, K24 DK098311, R01 CA137178]
  2. Paula and Russell Agrusa Fund for Colorectal Cancer Research
  3. Friends of the Dana-Farber Cancer Institute
  4. Bennett Family Fund
  5. Entertainment Industry Foundation through National Colorectal Cancer Research Alliance
  6. Uehara Memorial Foundation
  7. Japanese Society for the Promotion of Science
  8. Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research

Ask authors/readers for more resources

IMPORTANCE Marine omega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid, docosahexaenoic acid, and docosapentaenoic acid, possess potent immunomodulatory activity and may protect against cancer development. However, evidence relating marine.-3 PUFAs to colorectal cancer (CRC) risk remains inconclusive. OBJECTIVE To test the hypothesis that marine omega-3 PUFA intakemay be associated with lower risk of CRC subsets characterized by immune infiltrate. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort studywas conducted among participants in the Nurses' Health Study (1984-2010) and Health Professionals Follow-up Study (1986-2010). EXPOSURES Intake of marine omega-3 PUFAs. MAIN OUTCOMES AND MEASURES Incidence of CRC characterized by CD3(+), CD8(+), CD45RO (PTPRC)(+), or FOXP3(+) T-cell densities in tumor tissue, measured by immunohistochemical and computer-assisted image analysis. RESULTS Among 173 229 predominantly white participants, 125 172 with 2 895 704 person-years of follow-up provided data about marine omega-3 PUFA intake every 4 years through a validated food frequency questionnaire and followed up for incident CRC evaluation. Of 2504 CRC cases, we documented 614 (252 men, 362 women) from which we could assess T-cell infiltration in the tumor microenvironment. The inverse association of marine omega-3 PUFAs intake with CRC risk differed according to FOXP3(+) T-cell infiltration: compared with intake of less than 0.15 g/d of marine omega-3 PUFAs, intake of at least 0.35 g/d was associated with a multivariable hazard ratio (HR) of 0.57 (95% CI, 0.40-0.81; P <.001 for trend) for FOXP3(+) T-cell-high tumors. In contrast, the HR for FOXP3(+) T-cell-low tumors was 1.14 (95% CI, 0.8-1.60) (P =.77 for trend; P =.01 for heterogeneity). No statistically significant differential association was found for high-density tumors (compared with low-density tumors) according to CD3(+), CD8(+), or CD45RO(+) cell density (P >=.34 for heterogeneity for all comparisons). In functional assays, the suppressive activity of regulatory T cells was approximately 2-fold lower (T-effector-cell proliferation, >= 64% vs 38%) when preincubated with docosahexaenoic acid at 50 mu M, 100 mu M, and 200 mu M concentrations than without docosahexaenoic acid (P <.001 for all comparisons). CONCLUSIONS AND RELEVANCE High marine omega-3 PUFA intake was associated with lower risk of CRC with high-level, but not low-level, FOXP3(+) T-cell density, suggesting a potential role of omega-3 PUFAs in cancer immunoprevention through modulation of regulatory T cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available